TP53 Arg72Pro polymorphism and skin cancer risk: a meta-analysis

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• The TP53 gene is crucial for cellular defense against DNA damage, particularly from UV radiation.
• Sequence variations in TP53 may influence an individual's susceptibility to developing skin cancer.
• The Arg72Pro polymorphism is a common variation within the TP53 gene.

Purpose of the Study:

• To investigate the association between the TP53 Arg72Pro polymorphism and the risk of developing skin cancer.
• To synthesize evidence from multiple studies through a comprehensive meta-analysis.

Main Methods:

• A meta-analysis was conducted on 15 case-control studies, including a total of 6,362 participants.
• Study quality was evaluated using a standardized scale.
• Statistical analysis employed a random-effects model to calculate odds ratios (ORs) and 95% confidence intervals (CIs).

Main Results:

• No significant association was found between TP53 genotypes and overall skin cancer risk across various genetic models.
• Stratified analyses by ethnicity and study quality did not reveal any significant associations in subgroups.
• The polymorphism showed no discernible effect on the risk of specific skin cancer subtypes, including melanoma, squamous cell carcinoma, and basal cell carcinoma.

Conclusions:

• This meta-analysis indicates that the TP53 Arg72Pro polymorphism has a limited role in determining skin cancer susceptibility.
• Further research may be needed to explore other genetic or environmental factors influencing skin cancer risk.